BLA (biologics license application)
The regulatory pathway for approval of biological products (including some peptides and proteins) by the FDA. Similar to an NDA but specifically for biologics derived from living organisms.
Frequently Asked Questions
What is BLA (biologics license application)?
The regulatory pathway for approval of biological products (including some peptides and proteins) by the FDA. Similar to an NDA but specifically for biologics derived from living organisms.
Why is BLA (biologics license application) important in peptide research?
Understanding bla (biologics license application) is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.
Related Terms
NDA (new drug application)
The formal application to the FDA requesting approval to market a new drug. Contains all clinical trial data, manufacturing details, and proposed labeling. Review takes 6–12 months.
FDA approvedA designation indicating the U.S. Food and Drug Administration has determined a drug is safe and effective for its labeled indication based on clinical trial evidence. FDA-approved peptides include semaglutide, tirzepatide, liraglutide, and PT-141.